Home > Newsletters > Drug Industry Daily > EMA Finalizes Guidance on Drug Marketing Authorization Renewals
Drug Industry Daily
July 5, 2012 | Vol. 11 No. 131
EMA Finalizes Guidance on Drug Marketing Authorization Renewals
Drug companies will have to submit updated safety and efficacy data, as well as an updated analysis of a drug’s risks and benefits when renewing marketing authorizations in the EU, according to an European Medicines Agency (EMA) final guideline on processing renewal applications.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.